Cargando…

IRF4 Is a Suppressor of c-Myc Induced B Cell Leukemia

Interferon regulatory factor 4 (IRF4) is a critical transcriptional regulator in B cell development and function. We have previously shown that IRF4, together with IRF8, orchestrates pre-B cell development by limiting pre-B cell expansion and by promoting pre-B cell differentiation. Here, we report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pathak, Simanta, Ma, Shibin, Trinh, Long, Eudy, James, Wagner, Kay-Uwe, Joshi, Shantaram S., Lu, Runqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144921/ https://www.ncbi.nlm.nih.gov/pubmed/21818355 http://dx.doi.org/10.1371/journal.pone.0022628

Ejemplares similares

Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia
por: Shukla, Vipul, et al.
Publicado: (2016)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

Inhibition of MYC by the SMARCB1 tumor suppressor
por: Weissmiller, April M., et al.
Publicado: (2019)

Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc
por: Lee, Minnkyong, et al.
Publicado: (2015)

Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
por: Welcker, Markus, et al.
Publicado: (2022)

B-cell precursor leukemias with MYC-rearrangement come into the limelight
por: Borkhardt, Arndt, et al.
Publicado: (2022)

MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages
por: Bae, Seyeon, et al.
Publicado: (2021)

Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression
por: Thakur, Ram Krishna, et al.
Publicado: (2009)

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
por: Ishiguro, Kazuya, et al.
Publicado: (2019)

Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Loosveld, Marie, et al.
Publicado: (2014)

Molecularly distinct models of zebrafish Myc-induced B cell leukemia
por: Borga, Chiara, et al.
Publicado: (2018)

IRF2–INPP4B-mediated autophagy suppresses apoptosis in acute myeloid leukemia cells
por: Zhang, Feng, et al.
Publicado: (2019)

Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs Is Critical for T Cell Priming
por: McDaniel, Margaret M., et al.
Publicado: (2020)

Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
por: Chaturvedi, Nagendra K., et al.
Publicado: (2019)

Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models
por: Pathak, Simanta, et al.
Publicado: (2011)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

Implication of IRF4 Aberrant Gene Expression in the Acute Leukemias of Childhood
por: Adamaki, Maria, et al.
Publicado: (2013)

B‐prolymphocytic leukemia (B‐PLL) with genetic aberrations involving MYC and TP53
por: Tamber, Gurdip Singh, et al.
Publicado: (2021)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia
por: Jones, Letetia, et al.
Publicado: (2010)

Transcriptional regulation of IFN-λ genes in Hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex
por: Lee, Hai-Chon, et al.
Publicado: (2014)

Expression of c-myc is not critical for cell proliferation in established human leukemia lines
por: Tidd, David M, et al.
Publicado: (2001)

C-Myc functions as a competing endogenous RNA in acute promyelocytic leukemia
por: Ding, Ye, et al.
Publicado: (2016)

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
por: Kling, Matthew J., et al.
Publicado: (2022)

Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
por: Xu, Xinyuan, et al.
Publicado: (2015)

THAP11 Functions as a Tumor Suppressor in Gastric Cancer through Regulating c-Myc Signaling Pathways
por: Zhang, Jing, et al.
Publicado: (2020)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines
Publicado: (1987)

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia
por: Mittal, Amit K., et al.
Publicado: (2013)

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2013)

NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status
por: Sayyadi, Mohammad, et al.
Publicado: (2020)

Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
por: Pan, Xiao-Na, et al.
Publicado: (2014)

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene
por: Lefebure, Marcus, et al.
Publicado: (2017)

Epigenetics, c-Myc and Aggressive B-cell Lymphomas
por: Zhang, Yizhuo, et al.
Publicado: (2012)

Zebrafish MYC-induced leukemia models: unique in vivo systems to study B and T cell acute lymphoblastic leukemia
por: Borga, Chiara, et al.
Publicado: (2019)

Matrine, a potential c-Myc inhibitor, suppresses ribosome biogenesis and nucleotide metabolism in myeloid leukemia
por: Zhong, Wang-Jing, et al.
Publicado: (2022)

Transcriptional repression of Myc underlies the tumour suppressor function of AGO1 in Drosophila
por: Zaytseva, Olga, et al.
Publicado: (2020)

TRIM14 expression is regulated by IRF‐1 and IRF‐2
por: Cui, Jingang, et al.
Publicado: (2019)

Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
por: Bjorklund, C C, et al.
Publicado: (2015)

c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation
por: Wu, Guixian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rcflar2kqc6qcjvigul6id8iur